MoziforĀ® (Plerixafor Injection USP 24mg/1.2ml, 20mg/ml) is a prescription injection used with G-CSF to mobilize hematopoietic stem cells for collection and transplantation in eligible patients. Use under medical supervision.

Category:
Description

MoziforĀ® (Plerixafor Injection USP 24mg/1.2ml)

It is a prescription medication that helps mobilize hematopoietic stem cells into the bloodstream for collection and autologous transplantation. Healthcare professionals commonly use it alongside granulocyte-colony stimulating factor (G-CSF). In addition, doctors may prescribe it for eligible patients with multiple myeloma and non-Hodgkin lymphoma.

Key Features

āœ” Contains Plerixafor 24mg/1.2ml (20mg/ml)
āœ” Supports stem cell mobilization
āœ” Works effectively with G-CSF therapy
āœ” Sterile injectable solution
āœ” Produced under strict quality standards

Indications

MoziforĀ® helps move hematopoietic stem cells into the peripheral blood for collection and transplantation. Therefore, it plays an important role in stem cell transplant procedures when prescribed by a healthcare professional.

Dosage & Administration

A qualified healthcare provider should administer this medication. Furthermore, the physician determines the appropriate dosage based on the patient’s condition and treatment plan.

Storage

Store according to the manufacturer’s instructions. Also, keep the product out of reach of children.

Important Safety Information

Use this product only under medical supervision. Before starting treatment, consult your doctor or pharmacist for complete prescribing information, warnings, contraindications, and possible side effects.